Cleanhearing Sono is the result of an international collaboration involving inventors, academics, clinicians, and hearing industry experts. Our goal is to develop accessible, evidence-based solutions for tinnitus.
Here are some of our milestones to date:
Cleanhearing company was formed after a meeting between our founders, Hidero Niioka and Gerald Neuwirth, an Austrian engineer, who had developed a medical device to successfully treat his own chronic noise-induced tinnitus. They agreed to collaborate in further developing the technology as a medical device for home use.
Kyoto University made an anchor investment so we could start work on the prototype. We established our world-class scientific advisory board and expanded our team to begin development.
We finalised the Sono prototype.
We closed our pre-seed funding round of US$ 1.3M and confirmed our manufacturing partners for mass production.
We were invited to enter the Falling Walls Venture competition for health technology startups and reached the global finals in Berlin where we were placed in the top 3 for our category.
We received our EN ISO 13485 certification and Class IIa medical device approval.
We completed the tooling by early 2021 and started on the first round of manufacturing and testing.
The Cleanhearing tinnitus app was released on the App Store and Google Play.
May- Dec. 2021
Sono went on sale in the UK and Europe. We later introduced our 2-month, 4-month and 6-month rental options.
The South Africa Health Products Regulatory Authority (SAHPRA) approved Sono as a tinnitus treatment in South Africa.
Thank you for following our journey so far. If you haven’t done so already, why not find out how Sono works or see answers to common FAQs ?